This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (54)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

William J. Quiñones-Baldrich, MD; Juan J. Hernandez, MD; Wesley S. Moore, MD

Arch Surg. 1991;126(4):507-511.

Abstract
• Between January 1970 and June 1988, a total of 45 patients with aortic prosthetic graft infection underwent removal of the infected aortic prosthesis. In addition, 36 of these patients also underwent revascularization via an extra-anatomic bypass. We analyzed the early and long-term results with respect to survival, limb salvage, freedom from infection, and extra-anatomic graft patency. The 30-day mortality was 24% (11/45), and the amputation rate was 11% (8/73). During a mean follow-up of 36 months (range, 2 to 144 months), 80% (24/30) of the patients remained free of infection and are considered cured. Infection in the extraanatomic bypass graft was the most common cause of recurrent sepsis and the leading cause of late amputations (four of seven). By life-table methods, 1-year survival was 63% and 5-year survival was 49%. Limb salvage rates at 1 and 5 years were 79% and 66%, respectively. The primary patency rate of extra-anatomic bypass was 43% at 3 years, with the secondary patency rate improved to 65%. These early and late results are in marked contrast to the natural history of untreated aortic graft infection. Nonetheless, a perioperative mortality rate of 24%, a 5-year limb loss rate of 33%, and 3-year graft thrombosis rate of 35% are testimony to the serious nature of aortic graft infection and the need to develop better methods to prevent this complication.

(Arch Surg. 1991;126:507-511)

Author Affiliations
From the Section of Vascular Surgery, UCLA Medical Center.

Footnotes
Accepted for publication August 9, 1990.

Read before the Fifth Annual Meeting of the Western Vascular Society, Coronado Island, Calif, January 28, 1990.

Reprint requests to the Section of Vascular Surgery, UCLA Medical Center, 10833 LeConte Ave, Los Angeles, CA 90024-6904 (Dr Quiñones-Baldrich).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Graft Infectivity of Rifampin and Silver-Bonded Polyester Grafts to MRSA Contamination
Schmacht et al.
VASC ENDOVASCULAR SURG 2005;39:411-420.
ABSTRACT  

The Superficial Femoral-Popliteal Vein Graft: A Reliable Conduit for Large-Caliber Arterial and Venous Reconstructions
Seidel et al.
PERSPECT VASC SURG ENDOVASC THER 2001;14:57-80.
ABSTRACT  

Treatment of Aortic Graft Infection with Cryopreserved Aortic Allografts
Noel et al.
PERSPECT VASC SURG ENDOVASC THER 2000;13:55-64.
ABSTRACT  

Management of infected aortic grafts: development of less invasive surgery using cryopreserved homografts
Vogt and Turina
Ann. Thorac. Surg. 1999;67:1986-1989.
ABSTRACT | FULL TEXT  

Muscle Flaps in the Management of Prosthetic Graft Infections
Perler
PERSPECT VASC SURG ENDOVASC THER 1999;10:19-33.
ABSTRACT  

Replacement of Infected Aortic Prostheses with Lower Extremity Deep Veins
Kakish and Clagett
PERSPECT VASC SURG ENDOVASC THER 1998;9:21-39.
ABSTRACT  

Management of Abdominal Aortic Prosthetic Graft Infection Requiring Emergent Treatment
Mingoli et al.
ANGIOLOGY 1997;48:491-495.
ABSTRACT  

A New Option for Treatment of Infected Aortic Prostheses: The NAIS Operation
Clagett
PERSPECT VASC SURG ENDOVASC THER 1993;6:91-110.